关于DT的数据当下甚少，且部分结果相互矛盾，多数缺乏对照组。专家意见认为DT可能对患者的预后产生负面影响。因此，西班牙罗西奥圣母医院进行了一项随机临床试验，旨在通过长达96周的全面评估，对IR、IA/I、细胞相关HIV-DNA（CA-DNA）与未剪接 ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

根据在2024年IDWeek上展示的研究结果，ibalizumab更频繁地被选用于晚期HIV患者，大多数受试者保持治疗超过两年，显示出持久性。该研究旨在为这组经常面临多重耐药问题的患者群体提供长期临床结果和影响病毒学控制的因素的见解。

珍爱生命预防艾滋艾滋病防治宣传知识艾滋病，全称是“获得性免疫缺陷综合征”（英文名缩写AIDS）。它是由艾滋病病毒即人类免疫缺陷病毒（HIV）引起的一种病死率极高的恶性传染病。艾滋病病毒进入人体后，主要杀伤人体中的CD4+T淋巴细胞，使人的抵抗力逐渐下 ...

HIV and AIDS are not the same thing. HIV is a virus that attacks the body’s immune system, specifically white blood cells called CD4 T cells, which help the body fight infections. They are also ...

The Department of Health (DOH) on Friday urged the public to get tested early for human immunodeficiency virus-acquired ...

The Philippines' Department of Health (DOH) has expressed big concern over the rising number of newly diagnosed advanced HIV ...

HIV is an infection that attacks cells in your immune system, known as CD4 cells. If untreated, HIV may progress to acquired immunodeficiency syndrome (AIDS), which increases the risk of severe ...

The first presentation will take place in November 2024 at the HIV Drug Therapy 2024 conference in Glasgow , Scotland. During this event, Code Pharma will unveil promising early-stage results from ...

Detailed price information for Theratechnologies (TH-T) from The Globe and Mail including charting and trades.